David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Jack Alan Reynolds
Learn more about PhilPapers
Hastings Center Report 40 (6):18-20 (2010)
To celebrate forty years of publication, we asked people new to bioethics to tell us what should be next on the docket. We received 195 essays. Here are four we especially like. Bioethics has, until now, focused mainly on those who directly influence human health. It worked to establish guidelines for doctors to follow when treating their patients, and it provided a backbone for ethical human research. Bioethics has done a lot of good, but it is time for the field to branch out to things that affect human health in less obvious ways. Of the things that bioethics must turn its focus to, one of the most pressing issues is establishing a duty of care between pharmaceutical companies and the people they ..
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library|
References found in this work BETA
No references found.
Citations of this work BETA
No citations found.
Similar books and articles
Dan W. Brock (2000). Broadening the Bioethics Agenda. Kennedy Institute of Ethics Journal 10 (1):21-38.
Joo-Young Lee & Paul Hunt (2012). Human Rights Responsibilities of Pharmaceutical Companies in Relation to Access to Medicines. Journal of Law, Medicine and Ethics 40 (2):220-233.
Denis Gordon Arnold (ed.) (2009). Ethics and the Business of Biomedicine. Cambridge University Press.
Pepe Lee Chang (2006). Who's in the Business of Saving Lives? Journal of Medicine and Philosophy 31 (5):465 – 482.
Nicole Hassoun (2012). Global Health Impact: A Basis for Labeling and Licensing Campaigns? Developing World Bioethics 12 (3):121-134.
Michael L. Gross (2008). Why Treat the Wounded? Warrior Care, Military Salvage, and National Health. American Journal of Bioethics 8 (2):3 – 12.
J. S. Blumenthal-Barby (2012). Seeking Better Health Care Outcomes: The Ethics of Using the “Nudge”. American Journal of Bioethics 12 (2):1-10.
Daniel Wei L. Wang & Octavio Luiz Motta Ferraz (2012). Pharmaceutical Companies Vs. The State: Who Is Responsible for Post-Trial Provision of Drugs in Brazil? Journal of Law, Medicine and Ethics 40 (2):188-196.
Jessica Pierce (2002). Can Bioethics Survive in a Dying World? Journal of Medical Humanities 23 (1):3-6.
Wendy A. Rogers (2002). Is There a Tension Between Doctors' Duty of Care and Evidence-Based Medicine? Health Care Analysis 10 (3):277-287.
R. Stephen Parker & Charles E. Pettijohn (2003). Ethical Considerations in the Use of Direct-to-Consumer Advertising and Pharmaceutical Promotions: The Impact on Pharmaceutical Sales and Physicians. [REVIEW] Journal of Business Ethics 48 (3):279-290.
Michael J. Meyer (1992). Patients' Duties. Journal of Medicine and Philosophy 17 (5):541-555.
L. A. Jansen (2013). Between Beneficence and Justice: The Ethics of Stewardship in Medicine. Journal of Medicine and Philosophy 38 (1):50-63.
Onyeka K. Osuji & Okechukwu Timothy Umahi (2012). Pharmaceutical Companies and Access to Medicines – Social Integration and Ethical CSR Resolution of a Global Public Choice Problem. Journal of Global Ethics 8 (2-3):139-167.
Jessica Pierce (2004). The Ethics of Environmentally Responsible Health Care. Oxford University Press.
Added to index2010-11-12
Total downloads25 ( #74,055 of 1,101,944 )
Recent downloads (6 months)4 ( #91,857 of 1,101,944 )
How can I increase my downloads?